Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-16-113797

VP and Chief Compliance Office acquired 2,750 shares (grant or award)

  • VP and Chief Compliance Office gave up 1,633 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Herman James L VP and Chief Compliance Office 2016-04-06 Grant or award +2,750 $4.34 $11,935 44,217 D
Herman James L VP and Chief Compliance Office 2016-04-06 Shares withheld for taxes −1,633 $4.34 $7,087 42,584 D
Loading xslF345X03/doc4.xml…